Funding Research
Award Dinner
Thank you for your interest in the Miner’s Lamp Award!

One in five Canadians will experience mental illness in their lifetime. As seven in 10 people will encounter their first symptoms between ages 16 and 24, research into the causes of mental illness in young people remains essential.

The Miner’s Lamp Award Campaign has paved the way for new research in this area since 2016, thanks to a partnership between IAMGOLD Corporation, the University of Toronto Department of Psychiatry, and generous funding from diverse organizations and individuals.

While investing in young people’s mental health, we also honour those who have shown outstanding leadership in eroding the stigma of mental illness with the presentation of the Miner’s Lamp Award.

Please join us in giving young people the hope they need and the help they deserve by supporting the 2019 Miner’s Lamp Award Dinner.

A growing body of medical research highlighting the impact of mental illness, a greater understanding of its physiological origins and clearer evidence of its connection with physical health...all are cause for optimism in the fight for better mental health.

We are building on this optimism by investing in an area that is underfunded compared to other leading causes of illness and disability: the prevention and early detection of severe mental illness in adolescents and young people.

Since 2016, the Miner’s Lamp Award Campaign has raised $2 million for innovative studies at the Department of Psychiatry.

All costs for the Miner's Lamp Award Dinner are covered by IAMGOLD Corporation or in-kind donations, so 100% of funds raised go directly into new research.
Now in its fourth year, the 2019 Miner’s Lamp Award Dinner will be held on Tuesday March 19 at The Carlu, Toronto.

The dinner brings together a memorable mix of influential, engaged Canadians from business and academia, accomplished individuals sharing their personal struggles with mental illness, and talented artists. With renewed hope, we celebrate progress and our shared commitment to improving mental health for generations to come.

Our 2018 event saw Dennis Trottier, Chief Mental Health Officer, KPMG, Miner's Lamp Award recipient, George Cope, President & CEO of BCE Inc and Bell Canada and founder of Bell Let's Talk, and distinguished Canadian athletes Clara Hughes and Tie Domi speak up for greater understanding of mental illness.

For the 2019 dinner, we are looking forward to another memorable evening, including:

· Presentation of the Miner’s Lamp Award to Margaret Trudeau, celebrated Canadian mental health advocate, honouring a lifetime of personal and professional commitment to mental health
· Keynote address and musical perfomance by special guests
· An exclusive gathering of 500 leaders from Canada’s business and academic communities
· An opportunity to meet and speak with world-class scientists and leading clinicians
· A promotional contest with incredible prizes

For full details of the 2019 Miner’s Lamp Award Dinner, including a summary of sponsorship benefits, please review this sponsorship package.

For more information and to reserve your sponsorship, please contact Gabrielle Dang ( or Jonathan Carson (
Since 2016, the Miner's Lamp Award has brought together leaders from across business and academia who are committed to giving people affected by mental illness the hope they need and the help they deserve.

Through their generosity, we have raised $2 million for ground-breaking research that is helping to define the future of mental healthcare.

Events since launch
$ 2 Million
Funds Invested
Your dollars at work
Every dollar donated to the Miner's Lamp Award Campaign supports new research into youth mental health. As all costs for the Miner's Lamp Award Dinner are covered by IAMGOLD Corporation or by in-kind donations, 100% of proceeds are invested into the field’s most promising studies. With the funds raised since 2016, five new research studies are under way at the Department of Psychiatry.
Dr. Aristotle Voineskos is Associate Professor of Psychiatry at the University of Toronto, Director of the Slaight Family Centre for Youth in Transition at the Centre for Addiction and Mental Health and Head of the Kimel Family Translational Imaging-Genetics Laboratory, CAMH. He is a Canada Research Chair in Neuroimaging of Schizophrenia.
Dr. Joanna Henderson is an Associate Professor in the Department of Psychiatry at the University of Toronto, Director of the Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health and Interim Implementation Director of the Cundill Centre for Child and Youth Depression at CAMH. She is also a Clinician Scientist in the Child, Youth and Emerging Adult Program at CAMH.
Drs. Henderson and Voineskos are studying new approaches to identifying early signs of psychosis spectrum symptoms. Read an interview with Drs. Henderson and Voineskos about their research here.
Dr. Vincenzo De Luca is an Associate Professor in the Department of Psychiatry at the University of Toronto, a Psychiatrist and Clinician Scientist in the Complex Mental Illness Program/Schizophrenia Services, the Geriatric Psychiatry Division and the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health.
De Luca is studying the interaction of early life adversities and schizophrenia vulnerability genes in young people – with a special focus on how this relates to suicide risk.
Dr. Benjamin Goldstein is a child and adolescent psychiatrist and Full Professor of Psychiatry, Pharmacology, and Psychological Clinical Science at the University of Toronto. He is Director of the Centre for Youth Bipolar Disorder and Director of Research in the Department of Psychiatry at Sunnybrook Health Sciences Centre.
Dr. Goldstein’s study will yield important advances regarding microvascular pathology as an underlying biological contributor to bipolar disorder, and may provide a new approach to early treatment and prevention of the illness.
Dr. Michael Kiang is an Associate Professor in the Department of Psychiatry at the University of Toronto, a Clinician-Scientist in the Temerty Centre for Therapeutic Brain Intervention at the Centre for Addiction and Mental Health (CAMH) and a Psychiatrist in the Schizophrenia Division of CAMH's Complex Mental Illness Program.
Dr. Kiang’s study focuses on auditory steady-state response (ASR) abnormalities within individuals with clinical high risk (CHR) for schizophrenia. It could yield an objective, rapidly-administered prognostic test for psychosis and thus help target treatment trials to those most at risk.
Dr. Nathan Kolla is an Assistant Professor of Psychiatry with U of T’s Faculty of Medicine and holds a number of other academic appointments with the university. He is Vice-President of Research and Academics of Waypoint Centre for Mental Health Care. He is a staff psychiatrist at the Centre for Addiction and Mental Health in the Minimum Secure Forensic Ward and a Clinician Scientist in CAMH’s Research Imaging Centre.
Dr. Kolla’s study explores whether it may be possible to prospectively identify young individuals who are at ultra-high risk for schizophrenia and violence. Findings of key biomarkers would also help reduce the stigmatization of all patients with schizophrenia as habitually violent.
What's new
Our 2018 Sponsors
Milroy, Anderson &
McCain Families
Labatt Family
Silver Sponsors
CIBC Capital Markets
Evans Investment Counsel
Magris Resources Inc.
Purves Redmond Limited
Bronze Sponsors
Agnico Eagle Mines Limited
CBT Associates/BEACON
Delaney Capital Management
Detour Gold
Emerging Markets Capital
Growthink Network
Kirkland Lake Gold
Morgan Stanley
New Gold
Paul, Weiss, Rifkind, Wharton & Garrison LLP
International SOS
Stikeman Elliott LLP
Blake, Cassels & Graydon LLP
Marsh Canada Limited
FM Global
PhaseNyne - WXN
Torys LLP
Ashlea Wessel
Donnelley Financial Solutions
Shaun Usmar
Award Winners
2016 Photography by Ashlea Wessel
2017 Photography by George Pimentel
2018 Photography by Ashlea Wessel & George Pimentel
Gabrielle Dang
Jonathan Carson
© 2018